You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Investigational

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir Injectable Suspension, Rilpivirine Injectable

Completed
  • Human Immunodeficiency Virus Type 1 (HIV-1)
  • Cabotegravir Injectable Suspension
  • Rilpivirine Injectable Suspension
  • Bakersfield, California
  • +31 more
May 31, 2023

Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Sep 15, 2023

Haemophilia A, Haemophilia A With Inhibitors Trial in Worldwide (NNC0365-3769 (Mim8) PPX)

Not yet recruiting
  • Haemophilia A
  • Haemophilia A With Inhibitors
  • NNC0365-3769 (Mim8) PPX
  • Los Angeles, California
  • +27 more
May 12, 2023

Tumors Trial in Worldwide (GSK3845097, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Jul 5, 2023

Thrombotic Microangiopathies, Hematopoietic Stem Cell Transplantation Trial in Worldwide (Biological: narsoplimab)

Recruiting
  • Thrombotic Microangiopathies
  • Hematopoietic Stem Cell Transplantation
  • Biological: narsoplimab
  • San Diego, California
  • +16 more
May 2, 2023

Overweight, Obese, Type 1 Diabetes Trial in United States (CT-868, CT-868 Pen Injector, : CT-868 Pen Injector, Placebo)

Not yet recruiting
  • Overweight
  • +2 more
  • La Jolla, California
  • +15 more
Sep 29, 2023

Overweight, Obesity Trial in China (Semaglutide, Semaglutide Placebo)

Not yet recruiting
  • Overweight
  • Obesity
  • Beijing, Beijing, China
  • +14 more
May 26, 2023

Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir - Injectable Suspension (CAB LA), Rilpivirine -

Active, not recruiting
  • Human Immunodeficiency Virus Type 1 (HIV-1)
  • Cabotegravir - Injectable Suspension (CAB LA)
  • Rilpivirine - Injectable Suspension (RPV LA)
  • Macon, Georgia
  • +29 more
May 31, 2023

Arthritis, Rheumatoid Trial in Worldwide (Otilimab (GSK3196165), csDMARD(s))

Active, not recruiting
  • Arthritis, Rheumatoid
  • Anniston, Alabama
  • +382 more
Jan 24, 2023

Respiratory Syncytial Virus Infections Trial in New Zealand, Panama, South Africa (RSVPreF3 OA investigational vaccine, FLU-QIV)

Completed
Has Results
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • FLU-QIV
  • Auckland, New Zealand
  • +13 more
Sep 20, 2022

Polycystic Kidney, Autosomal Dominant Trial in Worldwide (Venglustat GZ402671, Placebo)

Terminated
Has Results
  • Polycystic Kidney, Autosomal Dominant
  • Birmingham, Alabama
  • +94 more
Feb 1, 2023

Systemic Lupus Erythematosus Trial in Worldwide (BENLYSTA, SLE treatment)

Active, not recruiting
  • Systemic Lupus Erythematosus
  • BENLYSTA
  • SLE treatment
  • Birmingham, Alabama
  • +177 more
Jan 23, 2023

Chronic Rhinosinusitis With Nasal Polyps Trial in China (Dupilumab, Placebo, Budesonide)

Recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • Beijing, China
  • +9 more
May 31, 2023

SGA, Turner Syndrome, Noonan Syndrome, ISS Trial (Somapacitan, Norditropin®)

Recruiting
  • SGA, Turner Syndrome, Noonan Syndrome, ISS
  • Birmingham, Alabama
  • +163 more
Feb 2, 2023

Nasal Polyps Trial in Worldwide (Depemokimab (GSK3511294), Placebo)

Recruiting
  • Nasal Polyps
  • Depemokimab (GSK3511294)
  • Placebo
  • Roseville, California
  • +84 more
Jan 19, 2023

Neovascular Age-related Macular Degeneration Trial in Worldwide (SOK583A1 (40 mg/mL), Eylea EU (40 mg/mL))

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • SOK583A1 (40 mg/mL)
  • Eylea EU (40 mg/mL)
  • Phoenix, Arizona
  • +101 more
Jan 23, 2023

Rheumatoid Arthritis (RA) Trial in Worldwide (NI-071, Infliximab)

Completed
Has Results
  • Rheumatoid Arthritis
  • Little Rock, Arkansas
  • +133 more
Jan 26, 2023

Obesity Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)

Recruiting
  • Obesity
  • Birmingham, Alabama
  • +225 more
Jan 24, 2023

Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors Trial in Worldwide (Concizumab)

Active, not recruiting
  • Haemophilia A Without Inhibitors
  • Haemophilia B Without Inhibitors
  • Los Angeles, California
  • +88 more
Feb 2, 2023

Diabetes, Type 2, Peripheral Arterial Disease Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Recruiting
  • Diabetes Mellitus, Type 2
  • Peripheral Arterial Disease
  • Birmingham, Alabama
  • +179 more
Jan 23, 2023

Asthma Trial in United States (TEV-56248, Albuterol sulfate)

Recruiting
  • Asthma
  • Westminster, California
  • +8 more
Sep 28, 2023

Primary Adrenal Insufficiency Trial in Germany, United Kingdom (Chronocort, Plenadren)

Recruiting
  • Primary Adrenal Insufficiency
  • Hamburg, Germany
  • +7 more
Feb 2, 2023

Nasal Polyps Trial in Worldwide (Depemokimab (GSK3511294), Placebo)

Recruiting
  • Nasal Polyps
  • Depemokimab (GSK3511294)
  • Placebo
  • Tucson, Arizona
  • +79 more
Jan 19, 2023

Nasal Polyps Trial in China, Japan, Russian Federation (Mepolizumab, Placebo, Standard of care)

Active, not recruiting
  • Nasal Polyps
  • Dongguan, Guangdong, China
  • +60 more
Jan 10, 2023

HIV Trial in Worldwide (Cabotegravir Tablets, Cabotegravir Injectable Suspension (CAB LA), Rilpivirine Tablets)

Active, not recruiting
  • HIV Infections
  • Cabotegravir Tablets
  • +4 more
  • Bakersfield, California
  • +116 more
Jan 22, 2023